Appili Therapeutics Inc. (APLIF)
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027
Disclosure of Interest/ Changes in Interest of Trustee-Manager/ Responsible Person: Changes in Interest of Trustee-Manager/ Responsible Person
GIL Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Gildan Activewear Inc.
Infleqtion Reports Updated Financial Results for Q2 2026 and FY26 Revenue Guidance
Robbins LLP Urges BZAI Stockholders Who Lost Money Investing in Blaize Holdings, Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit
Gray Announces Pricing of $750 Million of 7.500% Senior Secured First Lien Notes due 2034
Robbins LLP Urges SPRY Stockholders Who Lost Money Investing in ARS Pharmaceuticals Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit